Transcatheter aortic valve implantation access sites: same goals, distinct aspects, various merits and demerits
O Katsaros, A Apostolos, N Ktenopoulos… - Journal of …, 2023 - mdpi.com
Transcatheter aortic valve implantation (TAVI) has been established as a safe and
efficacious treatment for patients with severe symptomatic aortic stenosis (AS). Despite …
efficacious treatment for patients with severe symptomatic aortic stenosis (AS). Despite …
See It Best: A Propensity-Matched Analysis of Ultrasound-Guided versus Blind Femoral Artery Puncture in Balloon-Expandable TAVI
M Gennari, A Maccarana, G Severgnini… - Journal of Clinical …, 2024 - mdpi.com
Background: Currently, transcatheter aortic valve implantation (TAVI) is the standard
procedure recommended for patients over 75 years of age with symptomatic aortic valve …
procedure recommended for patients over 75 years of age with symptomatic aortic valve …
The role of external iliac artery diameter indexed to BSA score in predicting vascular access complications after transfemoral transcatheter aortic valve implantation
M Gruz-Kwapisz, T Gasior, A Hajder… - … Cardiology/Postępy w …, 2024 - termedia.pl
Aim: To investigate the correlation between external iliac artery diameter (EIAD) indexed to
body surface area (BSA)(EIAD-BSA) and access site complications in patients undergoing …
body surface area (BSA)(EIAD-BSA) and access site complications in patients undergoing …